Ulcerative Colitis Clinical Trials in Chicago

Showing 461-480 of 806 trials

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance

NCT02254317

The objective is to identify the lowest effective dose of Grape Seed Extract (GSE) on glucose control in people with impaired glucose tolerance (IGT).

Impaired Glucose Tolerance

Clinical Nutrition Research Center, Illinois Institute of Technology16 participantsStarted Sep 2014

Chicago, Illinois, United States

TERMINATEDPhase 32.2 miles

Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

NCT02587351

This is a multicenter, prospective, randomized, double-blind, placebo-controlled trial that will enroll 1028 patients with at least moderately severe COPD over a three year period and follow them at regular intervals for one year. The primary endpoint is time to first acute exacerbation. Secondary endpoints include rates and severity of COPD exacerbations, cardiovascular events, all-cause mortality, lung function, dyspnea, quality of life and metoprolol-related side effects.

Pulmonary Disease, Chronic Obstructive

University of Minnesota532 participantsStarted May 2016

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Fresno, California, United States +24 more locations

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance

Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Ulcerative Colitis Trials in Other Cities

Mind-Body Medicine and Ulcerative Colitis

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

An Educational Intervention to Improve Disease Management Knowledge of Hospitalized Patients With COPD

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy

ThermoSmart® Versus Conventional Humidification in Continuous Positive Airway Pressure (CPAP)

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy

Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)

An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy

VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms

Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy

Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada

Other Conditions in Chicago